ProMab Biotechnologies
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2600 Hilltop Dr Ste C320, Richmond, Cali...Phone Number
(510) 860-4615Website
www.promab.comRevenue
$8.3 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
2
1
1
1
About ProMab Biotechnologies
ProMab specializes in custom antibody production, CAR-T services, and mRNA-LNP development, catering to the needs of clients in the biotechnology and pharmaceutical sectors. Their offerings include a wide range of primary antibodies, full-length proteins, and CAR-T/NK cells, along with various specialized services such as CAR-T development and protein expression. The company prides itself on leveraging cutting-edge technologies to advance cancer treatment and therapeutic applications. With a strong portfolio of over 5,000 monoclonal antibodies generated and numerous clinical trials, ProMab is positioned as a leader in the field of biotechnology.Explore more
ProMab Biotechnologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ProMab Biotechnologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once ProMab Biotechnologies has new funding data
Product Launch: Get notified when ProMab Biotechnologies launches new products
ProMab Biotechnologies, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on ProMab Biotechnologies recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if ProMab Biotechnologies has recently received funding, and reach out quickly before it becomes old news!
Check out if ProMab Biotechnologies is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at ProMab Biotechnologies
Click to see if ProMab Biotechnologies had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at ProMab Biotechnologies
Find 2 more new buyers
Compare Similar Companies to ProMab Biotechnologies
Compare insights from companies similar to ProMab Biotechnologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ProMab Biotechnologies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ProMab Biotechnologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ProMab Biotechnologies.
ProMab Biotechnologies financials insights
Gather financial insights about ProMab Biotechnologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
ProMab Biotechnologies Tech Stack
A closer look at the technologies used by ProMab Biotechnologies
Most Recent Scoops
Event
Product Marketing, Events, Training, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Technology
Event
Product Marketing, Events, Software, Field /Outside Sales, Field Marketing, Healthcare Operations, Healthcare Technology
Facilities Relocation / Expansion
ProMab Biotechnologies is planning to move offices in January 2025. The move will impact approximately 30 employees at the existing office located at 2600 Hilltop Dr Bldg. B, Suite C320, Richmond, CA.
Facilities Relocation/Expansion
Event
Events
Funding
ProMab Biotechnologies News & Media
Caribou Biosciences and ProMab Biotechnologies Announce Sale and Assignment Agreement for Humanized scFv Targeting BCMA
BERKELEY, Calif. & RICHMOND, Calif.--(BUSINESS WIRE)--Caribou Biosciences, Inc., a leading CRISPR genome editing company, and ProMab Biotechnologies, Inc., a biotechnology CRO/CDMO specializing in antibody engineering and CAR-T development, today announced a sale and assignment agreement under which Caribou gains access to a ProMab humanized single-chain variable fragment (scFv) targeting the B Cell Maturation Antigen (BCMA) for use in allogeneic engineered cell therapies. Caribou intends toNantKwest Signs Worldwide License Agreement with ProMab Biotechnologies to Exclusively Develop Select Next Generation Targeted Natural Killer Cell Therapeutics
SAN DIEGO--(BUSINESS WIRE)--NantKwest, Inc. (Nasdaq:NK), a leading clinical-stage Natural Killer (NK) cell based therapeutics company, and ProMab Biotechnologies today announced the establishment of a worldwide license to a B-Cell Maturation Antigen (BCMA) targeted antibody sequence for multiple myeloma along with an option for up to five undisclosed targeting sequences for exclusive use in the development of chimeric antigen receptor (CAR) based NK cell therapies. “We are pleased to announce t
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding ProMab Biotechnologies
Sign Up For FreeTo access detailed company insights
ProMab specializes in custom antibody production, CAR-T services, and mRNA-LNP development, catering to the needs of clients in the biotechnology and pharmaceutical sectors. Their offerings include a wide range of primary antibodies, full-length proteins, and CAR-T/NK cells, along with various specialized services such as CAR-T development and prot... Read More
